Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04290546
Title CIML NK Cell in Head & Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

paranasal sinus cancer

laryngeal squamous cell carcinoma

oropharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

hypopharynx cancer

Therapies

ALT-803 + CIML-NK cells + Ipilimumab

ALT-803 + CIML-NK cells

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.